Ginsberg, Gary; Shani, Segev; Lev, Boaz - In: PharmacoEconomics 13 (1998) 2, pp. 231-241
In this study, the benefits and costs of treating schizophrenia with either risperidone or clozapine were examined. The lifetime drug-treatment cost incurred by a patient with schizophrenia in Israel was $US7561 (1996 values) with an initial 6-month trial with risperidone, compared with $US6326...